Propanc Biopharma, Inc. — Investor Relations & Filings
Filings indexed
412
across all filing types
Latest filing
2026-05-14
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
PPCB
Propanc Biopharma, Inc. is a clinical-stage company developing cancer treatments focused on preventing tumor recurrence and metastasis. Its lead candidate, PRP, is a pancreatic proenzyme formulation designed to target and eradicate cancer stem cells. The therapeutic approach aims to suppress tumor progression by controlling cancer cell migration, inhibiting the formation of tumor blood vessels, and inducing cell death. The company's primary focus is on developing long-term therapies for patients with solid tumors, such as pancreatic cancer.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q | 2026-05-14 | English | |
| S-1 - Propanc Biopharma, Inc. (0001517681) (Filer) | 2026-04-10 | English | |
| PRE 14A - Propanc Biopharma, Inc. (0001517681) (Filer) | 2026-03-19 | English | |
| 8-K - PROPANC BIOPHARMA, INC. (0001517681) (Filer) | 2026-02-26 | English | |
| 10-Q Filing | 2026-02-17 | English | |
| S-1 Filing | 2026-02-02 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 46344653 | 10-Q | 2026-05-14 | English | ||
| 34033549 | S-1 - Propanc Biopharma, Inc. (0001517681) (Filer) | 2026-04-10 | English | ||
| 32989894 | PRE 14A - Propanc Biopharma, Inc. (0001517681) (Filer) | 2026-03-19 | English | ||
| 32893126 | 8-K - PROPANC BIOPHARMA, INC. (0001517681) (Filer) | 2026-02-26 | English | ||
| 30295325 | 10-Q Filing | 2026-02-17 | English | ||
| 30295480 | S-1 Filing | 2026-02-02 | English | ||
| 12446220 | 8-K | 2026-01-07 | English | ||
|
2025
8 filings
| |||||
| 12446222 | S-1 | 2025-12-30 | English | ||
| 12446223 | DEF 14C | 2025-12-29 | English | ||
| 12446224 | PRE 14C | 2025-12-10 | English | ||
| 12446225 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 12446227 | 10-Q | 2025-11-14 | English | ||
| 12446226 | 8-K | 2025-11-10 | English | ||
| 12446228 | 8-K | 2025-10-14 | English | ||
| 12446229 | 10-K | 2025-09-29 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aptose Biosciences Inc.
Clinical-stage company developing targeted precision medici…
|
APS | CA | Professional, scientific and te… |
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
Propanc Biopharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34906/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34906 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34906 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34906 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34906}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Propanc Biopharma, Inc. (id: 34906)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.